Drug to Prevent Preterm Births to Be Pulled From Market

  • 📰 WSJ
  • ⏱ Reading Time:
  • 3 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

The maker of Makena said it will stop selling the drug to prevent preterm births after a study couldn’t confirm the medicine worked

Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works Makena was the only drug approved by the FDA to reduce the risk of preterm birth in women with a history of early deliveries.

Covis Pharma Group said it will stop selling its
 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

just call it a supplement and nobody says diddly

How did it get approved in the first place?

Good, do aducanumab next.

Wtf are these things let out before we know this. Jesus f----- Christ

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 98. in SE

Sverige Senaste nytt, Sverige Rubriker